Topical rosiglitazone is an effective anti-scarring agent in the cornea.

PLoS One · 2013 · PMC3733781 · PMID 23940641

Europe PMC DOI

hedged sentence

0.0450

closest p · 0.9× alpha

0.0450

boldest claim

The sentences

marginally significantp = 0.045actually significant

There was no significant main effect of treatment (F(3,117) = 2.441, p = 0.068) - only of time (F(4,117) = 4.155, p = 0.003), and a marginally significant interaction between the two (F(12, 117) = 1.870, p = 0.045).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.